FDA Warning Wire: Plant Problems Behind Medtronic Recalls
Recalled Medtronic cardiac defibrillators were at the heart of two warning letters handed out by the U.S. Food and Drug Administration. The agency also cited presurgical swabs with iffy sterility made...To view the full article, register now.
Already a subscriber? Click here to view full article